InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Releases Q4, Year-End 2022 Financial and Corporate Report
March 28, 2023
TRxADE Health (NASDAQ: MEDS), a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, is reporting its financial results for the year ending Dec. 31, 2022. Highlights of the report include consolidated revenues of $11.4 million, a 16.4% increase compared to […]
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Date for Release of Q4, Year-End 2022 Financial Report
March 14, 2023
TRxADE Health (NASDAQ: MEDS), a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, is planning to report on its financial results for fourth quarter and year-end 2022 on March 27, 2023. The company noted that the financial results will be […]
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Subsidiary Signs New Telemedicine Services Agreement
December 6, 2022
TRxADE Health (NASDAQ: MEDS), an integrated drug-procurement, delivery and healthcare platform, announced that Bonum Health, its digital healthcare business subsidiary, has signed a preferred telemedicine services agreement with an independent group purchasing organization. The agreement outlines significant discounts for group members to access Bonum Health’s service platform of more than 100 pharmacies in the northeastern part […]
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Releases Q3 Financial Numbers, Corporate Highlights
November 8, 2022
TRxADE Health (NASDAQ: MEDS), a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, is reporting key results for quarter three 2022, which ended Sept. 30, 2022. As the company continues to expand its breakthrough digital care healthcare services IT platform […]
InvestorNewsBreaks – TRxADE Health Inc.’s (NASDAQ: MEDS) Bonum Health(TM) to Work with Insurance Brokers to Offer Telemedicine Services for SMB Employer Groups
October 26, 2022
TRxADE (NASDAQ: MEDS), an integrated drug procurement, delivery and health care platform, today announced that Bonum Health, its digital health care subsidiary, has struck a strategic services distribution agreement with multiple insurance brokerage firms. As a result, the company, which offers nationwide telemedicine services for humans in all 50 states and pets in select states, […]
InvestorNewsBreaks – Trxade Health Inc. (NASDAQ: MEDS) Announces Call to Discuss Upcoming 3Q Financial Results
October 25, 2022
TRxADE Health (NASDAQ: MEDS), a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, is planning to release corporate financial results for Q3 2022 next month. The company announced that it will release the information on Nov. 7, 2022, after market […]
InvestorNewsBreaks – Trxade Health Inc. (NASDAQ: MEDS) Enters into $1.8M Registered Direct Offering
October 5, 2022
TRxADE Health (NASDAQ: MEDS), a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, has entered into a securities purchase agreement with a single institutional investor. The agreement outlines the purchase of approximately $1.8 million of MEDS common stock, or prefunded […]
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Board Appointment of Leading Pharmaceutical Industry Expert
October 3, 2022
TRxADE (NASDAQ: MEDS) is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. The company today announced the appointment of Jeff Newell to the company’s board of directors. A previous member of the company’s advisory board, Newell will serve […]
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Launches TRxADE Prime Plus to Meet Customers’ Needs of On-Demand Inventory
August 30, 2022
TRxADE (NASDAQ: MEDS), an integrated drug procurement, delivery and health care marketplace platform that connects buyers and sellers, today announced the launch of the Trxade Prime Plus program. Released in collaboration with the company’s pharmaceutical wholesale business subsidiary, Integra Pharma Solutions LLC (d/b/a TRxADE Prime), the program will allow member pharmacies better access to over […]
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Strategic Board Appointment of Leading Pharmaceutical Industry Expert
August 16, 2022
TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced the appointment of Jeff Newell to the company’s advisory board. Newell is expected to serve as a strategic resource to TRxADE as it continues […]
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Releases Q2 Financial Report Showing Revenue Growth
July 26, 2022
TRxADE Health (NASDAQ: MEDS), a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, has reported its second-quarter 2022 financial and operational information, for the period ended June 30, 2022. According to the report, revenues for Q2 2022 increased 73%, totaling […]
InvestorNewsBreaks – Trxade Health Inc.’s (NASDAQ: MEDS) Integra Pharma Partners with Pharmaceutical Co. to Help Network Members Succeed
July 13, 2022
TRxADE Health (NASDAQ: MEDS), through its wholly owned pharmaceutical wholesale business, Integra Pharma Solutions LLC, has inked a distribution agreement with GALT Pharmaceuticals LLC. Integra currently distributes generic and brand medications directly in 34 states through its warehouse; the new partnership adds single-source and multisource products directly from GALT Pharmaceuticals to its offering, supporting Integra’s mission […]
InvestorNewsBreaks – Trxade Health Inc. (NASDAQ: MEDS) Announces Upcoming Earnings Call
July 12, 2022
TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, is planning on releasing its financial information for Q2 2022 after the market closes on July 25, 2022. The company announced that it will release the […]
InvestorNewsBreaks – Trxade Health Inc.’s (NASDAQ: MEDS) Bonum Health Unveils Televeterinary Services
May 19, 2022
TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, has partnered with its digital healthcare subsidiary Bonum Health to announce a new service: televeterinary services for pets. According to the announcement, Bonum Health, which provides […]
InvestorNewsBreaks – Trxade Health Inc. (NASDAQ: MEDS) Announces Q1 2022 Financial Numbers, Operational Highlights
May 10, 2022
TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, has released its first quarter 2022 financial results. Highlights of the report, which covers the period ended March 31, 2022, include revenues for the period totaling […]
InvestorNewsBreaks – Trxade Health Inc. (NASDAQ: MEDS) Announces Plans to Release Q1 2022 Financial Numbers
April 25, 2022
TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, will release its financial results for first quarter 2022 on May 9, 2022; a press release with the financial report will be released after the market […]
InvestorNewsBreaks – Trxade Health Inc. (NASDAQ: MEDS) Release Fourth-Quarter, Year-End Financial Results
March 29, 2022
TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, has reported its Q4 and fiscal year 2021 numbers. The company also reported operational highlights and noted that in 2022 it is continuing a strategic nationwide […]
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) to Release Fourth-Quarter, Year-End Financial Results
March 15, 2022
TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, has announced it will report its financial results for Q4 and year end 2021 later this month. The company said it will release the information on […]
InvestorNewsBreaks – TRxADE Group Inc. (NASDAQ: MEDS) Subsidiary Partners with Grocery Chain to Provide Deeply Discounted Telemedicine to Uninsured, Underinsured Customers
February 23, 2022
TRxADE Group (NASDAQ: MEDS), an integrated drug procurement, delivery, healthcare platform and health service company, through its subsidiary Bonum Health, has signed a deal with Coborn’s Inc. for discount telemedicine services. TRxADE will work with Coborn’s, a regional grocery chain with more than 120 food and pharmacy grocery stores located throughout the Midwest, to provide affordable […]
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS), Exchange Health LLC Collaborate to Form SOSRx.com
February 15, 2022
TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced the formation with Exchange Health LLC of a joint venture, SOSRx LLC, a pharmaceutical platform. According to the update, SOSRx will provide pharmaceutical manufacturers […]
InvestorNewsBreaks – TRxADE Group Inc. (NASDAQ: MEDS) Announces Participation in Aegis Virtual Conference
February 10, 2022
TRxADE Group (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, will be participating in the upcoming Aegis Capital Corp. Virtual Conference this month. The three-day conference is slated for Feb. 23–25, 2022. MEDS CEO Suren Ajjarapu […]
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Resumes Modified Stock Repurchase Program
December 13, 2021
TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced that its board of directors has authorized the resumption of the previously disclosed stock repurchase program, which the board modified to allow for the […]
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Launch of T-Rx(TM) Savings Card
November 30, 2021
TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced the launch of its TRxADE Discount Card. The new offering empowers independent pharmacies to continue providing their customers with deeply discounted drug pricing while […]
InvestorNewsBreaks – TRxADE Group Inc. (NASDAQ: MEDS) to Participate in Upcoming LD Micro Movers Virtual Event
November 18, 2021
TRxADE Group (NASDAQ: MEDS), a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, will be presenting at the LD Micro Movers Virtual Event. The virtual event, which focuses on notable small-cap companies of 2021, will take place Dec. 1, 2021. […]
InvestorNewsBreaks – TRxADE Group Inc. (NASDAQ: MEDS) Releases Q3 2021 Financial Report
October 26, 2021
TRxADE Group (NASDAQ: MEDS),a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, has reported its financial numbers for quarter three 2021, the period ended Sept. 30, 2021. Highlights of the report include a revenue increase of 34.3% over Q2 […]
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Planned Release of Q3 2021 Financial Results
October 11, 2021
TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced that it will release financial results for the third quarter of 2021 after market close on Oct. 25, 2021. According to the update, management […]
InvestorNewsBreaks – TRxADE HEALTH INC.’s (NASDAQ: MEDS) Bonum Health Launches eGift Card Program
August 10, 2021
TRxADE HEALTH (NASDAQ: MEDS), an integrated drug procurement, delivery and health care platform, today announced that its telehealth subsidiary, Bonum Health, has launched an electronic gift card program as an innovative new way for uninsured and under-insured consumers to gain access to health care. Bonum Health’s electronic gift cards (Bonum Health eGift(TM)) are pre-paid digital […]
TRxADE HEALTH, INC. (NASDAQ: MEDS) Featured in Virtual Coverage of LD Micro’s Invitational XI
June 7, 2021
TRxADE HEALTH, INC. (NASDAQ:MEDS) is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. The Company operates the TRxADE drug procurement marketplace serving a total of 12,100+ members nationwide, fostering price transparency and under the Bonum Health brand, offering patient centric telehealth […]
InvestorNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Announces Name Change to Reflect New Mission, Strategic Direction
May 28, 2021
Trxade Group (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced that the company will be changing its name to TRxADE Health Inc. The change, effective Tuesday, June 1, 2021, reflects the company’s new mission […]
InvestorNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) to Present at Virtual Planet MicroCap Showcase
April 19, 2021
Trxade Group (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, will be presenting at the upcoming Planet MicroCap Showcase. Scheduled to take place on April 20–22, 2021, the virtual Planet MicroCap event will feature 66 small-cap, […]
InvestorNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Announces Planned Release of Q1 2021 Financial Results, Conference Call
April 13, 2021
Trxade Group (NASDAQ: MEDS),a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, has announced that it will its first-quarter 2021 financial results after market close on April 26, 2021. As part of that release, the company has scheduled a […]
InvestorNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Announces Plans to Present at Planet MicroCap Showcase
April 9, 2021
Trxade Group (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience, today announced that management will present at the Planet MicroCap Showcase, which is scheduled to take place virtually April 20-22, 2021. According to the update, Suren Ajjarapu, TRxADE Group’s chairman and chief executive officer, is scheduled to host a […]
InvestorNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Releases Quarter, FY 2020 Financial Report
March 30, 2021
Trxade Group (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, has reported its financial results for fourth quarter and fiscal year for the period ended Dec. 31, 2020. The report also included key operational highlights. Financial […]
InvestorNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Schedules Call, Will Release Q4 and FY 2020 Financial Results
March 16, 2021
Trxade Group (NASDAQ: MEDS), a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, has announced that it will report Q4 and FY 2020 financial results. MEDS will release the numbers, which are for the fourth quarter and fiscal year ended Dec. […]
InvestorNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Announces Participation in Upcoming Investor Conferences
March 5, 2021
Trxade Group (NASDAQ: MEDS), a technology-enabled health services platform company focused on digitalizing the retail pharmacy experience, will be participating in three investor conferences scheduled in March 2021. In all three conferences, Trxade Group CEO Suren Ajjarapu will present valuable information and insights about the company for conference participants. In addition, he is scheduled to participate in one-on-one […]
InvestorNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) to Postpone February Virtual Road Show
February 2, 2021
Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and healthcare platform, has announced that it will postpone its upcoming virtual road show. Trxade had previously announced that the road show event would be held Wednesday, Feb. 3, 2021, at 11 a.m. ET. The company, which operates across the United States in all 50 states, will reschedule […]
InvestorNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Slated to Host February Virtual Roadshow
January 20, 2021
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, has announced that it will be hosting a virtual roadshow next month. The event is scheduled for 11 a.m. ET on Wednesday, Feb. 3, 2021. Trxade Group CEO Suren Ajjarapu will host the presentation, which will include an overview of the company’s business model […]
InvestorNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Partners with KPH Healthcare Service to Provide Telehealth Services
December 10, 2020
Trxade Group (NASDAQ: MEDS), through its telehealth subsidiary Bonum Health, has signed a strategic agreement with KPH Healthcare Services (“KPH”), a leading pharmaceutical and healthcare services provider, to provide affordable telemedicine services to two KPH divisions. Trxade, an integrated drug procurement, delivery and healthcare platform, will work through Bonum to serve the patients of approximately 100 […]
InvestorNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Announces Launch of Trxade Prime Purchasing Solution
December 8, 2020
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and health care platform, today announced the launch of Trxade Prime, a revolutionary service offered by the company’s Integra Pharma Solutions subsidiary. According to the update, Trxade Prime solves a historic problem for independent pharmacies suffering from an already complex prescription distribution process. The solution allows […]
InvestorNewsBreaks – Trxade Group Inc.’s (NASDAQ: MEDS) Platform Meets Today’s Demands Through Intelligent Design
November 25, 2020
Trxade Group NASDAQ: MEDS), an integrated drug-procurement, delivery and health care platform, is ideally situated as the global pandemic has led to a cascade of changes involving how health care is administered, perhaps most notably in the increased adoption of telehealth services. Trxade Group’s business model appears to aptly and effectively meet today’s demands, largely […]